Novo Nordisk enters research collaboration with Flagship Pioneering

The venture capital firm brings its portfolio of life science firms to the table, while Novo Nordisk has funding at the ready for any research program that might stem from the partnership.
Photo: Stine Tidsvilde
Photo: Stine Tidsvilde
by marketwire, translated by daniel pedersen

Novo Nordisk and Flagship Pioneering, a life science venture capital firm based in the US, have struck a deal concerning the latter’s life science portfolio of firms, a joint press release has announced.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading